News
OYST
11.17
0.00%
0.00
Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7
Six out of the 10 largest holdings in 700 hedge fund portfolios are increasingly concentrated towards the 'Magnificent Seven' stocks. Tesla is the sole exception. The Magnificent Seven accounts for a record 13% of the aggregate hedge fund long portfolios. Goldman Sachs report shows a cautious approach to mega-caps.
Benzinga · 02/21 17:02
More
Webull provides a variety of real-time OYST stock news. You can receive the latest news about Oyster Point Pharma, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About OYST
Oyster Point Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of pharmaceutical therapies to treat ophthalmic diseases. The Company's lead product candidate is TYRVAYA Nasal Spray, a nicotinic acetylcholine receptor (nAChR) agonist for the treatment of the signs and symptoms of dry eye disease. TYRVAYA Nasal Spray’s is a mechanism of action, which is designed to re-establish tear film homeostasis by stimulating the trigeminal nerve, activating the trigeminal parasympathetic pathway (TPP) and stimulating the glands and cells responsible for natural tear film production. It is sprayed into the anterior portion of the nasal cavity and stimulates nAChRs located on the chemosensory endings of the trigeminal nerve resulting in cholinergic neurotransmission.